TY - BOOK ID - 214243 TI - The GABA receptors AU - Enna, S. J. AU - Mohler, Hanns. PY - 2007 SN - 1280971789 9786610971787 1597454656 1588298132 1627038957 PB - Totowa, N.J. : Humana Press, DB - UniCat KW - GABA KW - Receptors. KW - Aminobutyric acid KW - GABA receptors KW - Receptors, GABA KW - Cell receptors KW - Neurotransmitter receptors KW - Receptors KW - Neurosciences. KW - Toxicology. KW - Cytology. KW - Psychiatry. KW - Pharmacology/Toxicology. KW - Cell Biology. KW - Cell biology KW - Cellular biology KW - Biology KW - Cells KW - Cytologists KW - Chemicals KW - Medicine KW - Pharmacology KW - Poisoning KW - Poisons KW - Neural sciences KW - Neurological sciences KW - Neuroscience KW - Medical sciences KW - Nervous system KW - Medicine and psychology KW - Mental health KW - Psychology, Pathological KW - Toxicology KW - Pharmacology. KW - Cell biology. KW - Drug effects KW - Medical pharmacology KW - Chemotherapy KW - Drugs KW - Pharmacy KW - Physiological effect UR - https://www.unicat.be/uniCat?func=search&query=sysid:214243 AB - This volume is the third edition of a monograph series that was first published in 1983. The demand for this work is a testament to the impact of studies on -aminobutyric acid (GABA) receptors on the basic understanding of synaptic transmission and on defining the clinical importance of the neurotransmitter system. Chronicled in The GABA Receptors, Third Edition, are the advances made in understanding the molecular and pharmacological properties of GABA A and GABA receptors since the topic was last reviewed in 1996. Particular B emphasis is placed on describing the assembly, structure, and function of GABA B sites, the first heterodimeric G protein-coupled receptors identified in vivo. In addition, there are reports dealing with the subunit composition, trafficking, and pharmacological selectivity of GABA receptors. Aside from providing A insights into the fundamental properties of ligand-gated ion channels and second messenger systems, the findings detailed in this work point the way for developing novel therapeutics capable of more selectively manipulating these transmitter sites. ER -